Neonatal Caffeine Treatment and Respiratory Function at 11 Years in Children under 1,251 g at Birth.

Doyle, Lex W; Ranganathan, Sarath; Cheong, Jeanie L Y

Doyle, Lex W; Ranganathan, Sarath; Cheong, Jeanie L Y.

Affiliation

Doyle LW; 1 Neonatal Services, Royal Women's Hospital, Melbourne, Australia.
Ranganathan S; 2 Department of Obstetrics and Gynaecology and.
Cheong JLY; 3 Department of Paediatrics, The University of Melbourne, Melbourne, Australia.

Am J Respir Crit Care Med ; 196(10): 1318-1324, 2017 11 15.

Article in En | MEDLINE | ID: mdl-28707987

Subject(s)

Apnea/drug therapy; Apnea/etiology; Bronchopulmonary Dysplasia/drug therapy; Bronchopulmonary Dysplasia/etiology; Caffeine/therapeutic use; Infant, Premature, Diseases/drug therapy; Respiration, Artificial/adverse effects; Child; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Male; Odds Ratio; Respiratory Function Tests

Key words

airway obstruction; bronchopulmonary dysplasia; caffeine; childhood; newborn infant

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Apnea / Respiration, Artificial / Bronchopulmonary Dysplasia / Caffeine / Infant, Premature, Diseases Type of study: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Child / Female / Humans / Male / Newborn Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2017 Document type: Article Affiliation country: Australia Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google